OTHER ASPECTS OF CV
1963: General Medical Council, London (registration number 0404738)
MEDICAL REGISTRATION AND LICENSURE
1977: State of New York (license number: 130659)
1978: State of Maryland (license number: D21721)
1978: District of Columbia (license number: 11165)
1995: Royal Netherlands Medical Association Specialist Registration in Gastroenterology
1. A quantitative study on the survival of X-irradiated spermatogonia in the rat. Submitted for the degree of Hons. B.Sc. in Anatomical Studies of the University of Birmingham (Faculty of Science), UK, 1959 (preceptors: Professor Sir Solly Zuckerman, O.M., F.R.S. and Dr. Anita M Mandl, D.Sc.).
2. Quantitative studies of nitrogen metabolism in vivo utilizing carbon-labeled carbonate and urea. Submitted for the degree of Doctor of Medicine of the University of Birmingham, UK, 1969.
3. Hepatic encephalopathy and the GABAA receptor complex. Submitted for the degree of Doctor of Science (in Medicine) of the University of Birmingham, UK, 1991.
1. Association of Physicians of Great Britain and Ireland (since 1975) (current)
MEMBERSHIP OF MEDICAL SOCIETIES (present or former)
2. American Society for Clinical Investigation (since 1977) (current)
3. Royal Society of Medicine (London) (current)
4. Medical Research Society (UK)
5. British Society of Gastroenterology
6. Membre Etranger de la Societe Belge de Gastroenterologie
7. American Association for the Study of Liver Diseases
8. International Association for the Study of the Liver
9. Asian Pacific Association for the Study of the Liver
1. Training and Education Committee, American Association for the Study of Liver Diseases (1979-1983).
2. Quality Assurance Committee, Clinical Center, National Institutes of Health, Bethesda, Maryland (1986-1992).
3. Ad Hoc Committee for Hepatology Training, American Association for the Study of Liver Diseases (1989-1992). (see bibliography: medical education no. 1).
4. Abstract Selection Committees for meetings of the American Association for the Study of Liver Diseases, the International Association for the Study of the Liver, and the World Congress of Gastroenterology.
5. Institute Clinical Research Subpanel (NIDDK/NIAMSD), National Institutes of Health, Bethesda, Maryland (1992) (committee responsible for assessing the ethics of clinical research protocols).
6. International Scientific Advisory Committees for the 7th (1990), 8th (1993), 10th (1999), and 12th (2005) International Symposia on Hepatic Encephalopathy and Nitrogen Metabolism (formerly International Symposia on Ammonia).
7. Publications Committee, American Association for the Study of Liver Diseases (1992).
8. Ad Hoc (European) Group for the Respect of Ethics and Excellence in Science (a group concerned with developing guidelines for the registration of new drugs) (1994-1997). (see bibliography: drug regulation nos. 1 - 3).
9. Organization Committee, 4th Amsterdam International Update on Hepatology, Amsterdam, Netherlands (2004).
1. Training and Education Committee, American Association for the Study of Liver Diseases (1981-1982).
2. Abstract Selection Committees for meetings of the American Association for the Study of Liver Diseases.
3. Abstract Selection Committee for Complications of Cirrhosis, Eleventh World Congress of Gastroenterology, Vienna, Austria, 1998.
4. Organisation Committees for the 1st (1997), 2nd (1998) and 3rd (2000) Amsterdam International Updates on Hepatology, Amsterdam, Netherlands.
5. Organisation Committee for the 11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism, Amsterdam, Netherlands, 2002.
1. Journal of Hepatology (1984-1991, 2000-2007).
2. Gastroenterology (1980-1984).
3. Hepatology (1984-1988, and 1991-2001).
4. Journal of Gastroenterology and Hepatology.
5. World Journal of Gastroenterology.
1. Jones EA (Editor). Queen's Medical Magazine. (The Journal of the University of Birmingham Medical School, UK), 1961-1962.
2. Jones EA (Editor). Primary Biliary Cirrhosis. Seminars in Liver Disease. Volume 1, Number 4. New York: Thieme-Stratton, 1981.
3. Jones EA (Guest Editor). Gastroenterology, 1985.
4. Thomas HC, Jones EA (Editors). Recent Advances in Hepatology. Volume 2. Edinburgh: Churchill Livingstone, 1986.
5. Hoofnagle JH, Jones EA (Editors). Interferon Therapy of Chronic Viral Hepatitis. Seminars in Liver Disease. Volume 9, Number 4. New York: Thieme Medical, 1989.
6. Jones EA, Meijer AJ, Chamuleau RAFM (Editors). Encephalopathy and Nitrogen Metabolism in Liver Failure. London: Kluwer Academic, 2003.
7. Zylicz Z, Twycross R, Jones EA (Editors). Pruritus in Advanced Disease. Oxford: Oxford University Press, 2004.
8. van Lanschot JJB, Gouma DJ, Jansen PLM, Jones EA, Pinedo HM, Schouten WR, Tytgat GNJ (Editors). Integrated Medical and Surgical Gastroenterology. Houten/Diegem, Netherlands: Bohn Stafleu Van Loghum, 2004; and New York: Thieme Medical Publishers, 2006.
Organizations for which grant proposals have been reviewed include:
REVIEWER OF GRANT PROPOSALS
Canadian Medical Research Council.
Medical Research Council of New Zealand.
Veterans Administration (USA.).
Food and Drug Administration (USA).
Netherlands Association for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek).
Journals for which articles have been reviewed include:
REVIEWER FOR MEDICAL JOURNALS
American Journal of Medicine
American Journal of Physiology
Annals of Internal Medicine
Archives of Internal Medicine
European Journal of Gastroenterology and Hepatology
Journal of Clinical Investigation
Journal of Gastroenterology and Hepatology
Journal of Hepatology
Journal of Immunology
Mayo Clinic Proceedings
New England Journal of Medicine
Proceedings of the National Academy of Sciences of the United States of America
1. Second Dame Sheila Sherlock Lecturer, University of Toronto, Canada.
2. Travelling Lecturer for the Asian Pacific Association for the Study of the Liver (1990).
1. Potter BJ. Complement activity in liver disease. Ph.D. (London), 1975.
PRECEPTOR FOR THESIS WORK
2. Owens D. Studies of the metabolism of bilirubin in health and disease. M.D. (Liverpool), 1975.
3. Balfour AH. The binding of plasma proteins to human placental cell membranes. Ph.D. (Liverpool), 1976.
1. Vrielink H. Laboratory diagnosis of viruses transmitted by blood transfusion. M.D. (Amsterdam), 1996.
MEMBERSHIP OF MEDICAL DOCTORATE THESIS COMMITTEES
2. Vogels B. Experimental hepatic encephalopathy: A central role of ammonia and portacaval shunting. M.D. (Amsterdam), 1996.
3. Quero Guillen JC. Subclinical hepatic encephalopathy: Diagnosis, clinical implications, and intervention. M.D. (Rotterdam), 1997.
4. van Milligen de Wit AWM. Primary sclerosing cholangitis: Aspects of pathogenesis and therapy. M.D. (Amsterdam), 1997.
5. Meyer H. Chronic hepatic encephalopathy: Studies into the pathogenesis and treatment in the dog. M.D. (Utrecht), 1998.
6. ter Borg F. E antigen negative chronic hepatitis B. M.D. (Amsterdam), 1998.
7. Giger-Vassela M. Visual event-related components in humans: a diagnostic tool for early detection of metabolic brain disorders. Ph.D. (Amsterdam), 2000.
8. Sentjens REJH. New developments in hepatitis B, C, and G virus. M.D. (Amsterdam), 2003.
1. Oral presentations of papers at the 61st and 67th Annual General Meetings of the Association of Physicians of Great Britain and Ireland -
(i) Jones EA. Treatment of hepatic coma due to acute hepatic necrosis by exchange blood transfusions. Quarterly Journal of Medicine 1967; 36: 604-605.
(ii) Jones EA. Some aspects of the molecular structure and functions of human immunoglobulin G. Quarterly Journal of Medicine 1973; 42: 835-836.
2. Panel Chief for Hepatology Consultative Services, National Institutes of Health, Bethesda, Maryland (1977-1992).
3. Member of the Faculty and Chairman of Program Sessions at meetings of the American Association for the Study of Liver Diseases, the International Association for the Study of the Liver, and the 1st, 2nd, 3rd and 4th Amsterdam International Updates on Hepatology.
4. Original holder of an IND from the Food and Drug Administration (USA) to assess the efficacy and safety of the experimental opiate antagonist, nalmefene, in patients with pruritus secondary to cholestatic liver diseases. (see bibliography: clinical trials nos. 15 and 17).
5. Assessment of the pharmacodynamics, pharmacokinetics, efficacy and safety of drugs (new chemical entities) for the Medicines Control Agency (Licensing Authority), Department of Health, London, UK (1993-1994).
6. International Adviser to the Royal College of Physicians, London (2000-2003) (and, subsequently, Emeritus International Adviser).
7. Member of an International Workshop (Washington, DC, 1996): Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis and Cartilege 1996; 4: 217-243.
8. Member of an International Workshop (11th World Congress of Gastroenterology, Vienna, Austria, 1998): Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantitation. Hepatology 2002; 35: 716-721.